A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma
Crossref DOI link: https://doi.org/10.1007/s12032-015-0526-x
Published Online: 2015-02-20
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Hongli
Sun, Guoxun
Kong, Desheng
Zhang, Yujing
Shi, Wudan
Zhao, Mingming
Hong, Luojia
Qiao, Zhenkui
Text and Data Mining valid from 2015-02-20